Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher D Verrico

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Synapse (New York, N.Y.)|April 24, 2003
Persistent and anatomically selective reduction in prefrontal cortical dopamine metabolism after repeated, intermittent cannabinoid administration to ratsChristopher D Verrico, J David Jentsch, Robert H Roth
Psychopharmacology|October 13, 2005
MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatmentChristopher D Verrico, Gregory M Miller, Bertha K Madras
Psychiatry Research|August 21, 2018
Psychosis and synthetic cannabinoidsHuiqiong Deng, Christopher D Verrico, Thomas R Kosten, et al.
Pain Management|June 10, 2026
Dronabinol for chronic low back pain in Veterans: protocol for a randomized, double-blind, placebo-controlled, parallel-group trialMichael Strayhorn, Adetola Vaughan, JeTaury Davis, et al.
Synapse (New York, N.Y.)|April 11, 2003
Systemic, but not local, administration of cannabinoid CB1 receptor agonists modulate prefrontal cortical acetylcholine efflux in the ratChristopher D Verrico, J David Jentsch, Laura Dazzi, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 25, 2003
Repeated, intermittent delta(9)-tetrahydrocannabinol administration to rats impairs acquisition and performance of a test of visuospatial divided attentionChristopher D Verrico, J David Jentsch, Robert H Roth, et al.
Schizophrenia Research|April 9, 2013
Endocannabinoid metabolism in the prefrontal cortex in schizophreniaDavid W Volk, Benjamin I Siegel, Christopher D Verrico, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 18, 2010
Cannabinoid CB1 receptor immunoreactivity in the prefrontal cortex: Comparison of schizophrenia and major depressive disorderStephen M Eggan, Samuel R Stoyak, Christopher D Verrico, et al.
Neuropharmacology|June 17, 2014
Short-term, low-dose varenicline administration enhances information processing speed in methamphetamine-dependent usersAri D Kalechstein, James J Mahoney, Christopher D Verrico, et al.
Brain Research|December 7, 2002
Adaptation of monoaminergic responses to phencyclidine in nucleus accumbens and prefrontal cortex following repeated treatment with fluoxetine or imipramineRichard De La Garza, J David Jentsch, Christopher D Verrico, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Synapse (New York, N.Y.)|April 24, 2003
Persistent and anatomically selective reduction in prefrontal cortical dopamine metabolism after repeated, intermittent cannabinoid administration to ratsChristopher D Verrico, J David Jentsch, Robert H Roth
Psychopharmacology|October 13, 2005
MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatmentChristopher D Verrico, Gregory M Miller, Bertha K Madras
Psychiatry Research|August 21, 2018
Psychosis and synthetic cannabinoidsHuiqiong Deng, Christopher D Verrico, Thomas R Kosten, et al.
Pain Management|June 10, 2026
Dronabinol for chronic low back pain in Veterans: protocol for a randomized, double-blind, placebo-controlled, parallel-group trialMichael Strayhorn, Adetola Vaughan, JeTaury Davis, et al.
Synapse (New York, N.Y.)|April 11, 2003
Systemic, but not local, administration of cannabinoid CB1 receptor agonists modulate prefrontal cortical acetylcholine efflux in the ratChristopher D Verrico, J David Jentsch, Laura Dazzi, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 25, 2003
Repeated, intermittent delta(9)-tetrahydrocannabinol administration to rats impairs acquisition and performance of a test of visuospatial divided attentionChristopher D Verrico, J David Jentsch, Robert H Roth, et al.
Schizophrenia Research|April 9, 2013
Endocannabinoid metabolism in the prefrontal cortex in schizophreniaDavid W Volk, Benjamin I Siegel, Christopher D Verrico, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 18, 2010
Cannabinoid CB1 receptor immunoreactivity in the prefrontal cortex: Comparison of schizophrenia and major depressive disorderStephen M Eggan, Samuel R Stoyak, Christopher D Verrico, et al.
Neuropharmacology|June 17, 2014
Short-term, low-dose varenicline administration enhances information processing speed in methamphetamine-dependent usersAri D Kalechstein, James J Mahoney, Christopher D Verrico, et al.
Brain Research|December 7, 2002
Adaptation of monoaminergic responses to phencyclidine in nucleus accumbens and prefrontal cortex following repeated treatment with fluoxetine or imipramineRichard De La Garza, J David Jentsch, Christopher D Verrico, et al.
Pageof 5